Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy
Different stimuli can polarize macrophages into two basic types, M1 and M2. Tumor-associated macrophages (TAMs) in the tumor microenvironment (TME) are composed of heterogeneous subpopulations, which include the M1 anti-tumor and M2 pro-tumor phenotypes. TAMs predominantly play a M2-like tumor-promo...
Gespeichert in:
| Veröffentlicht in: | Frontiers in immunology Jg. 13; S. 888713 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Frontiers Media S.A
30.06.2022
|
| Schlagworte: | |
| ISSN: | 1664-3224, 1664-3224 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Different stimuli can polarize macrophages into two basic types, M1 and M2. Tumor-associated macrophages (TAMs) in the tumor microenvironment (TME) are composed of heterogeneous subpopulations, which include the M1 anti-tumor and M2 pro-tumor phenotypes. TAMs predominantly play a M2-like tumor-promoting role in the TME and regulate various malignant effects, such as angiogenesis, immune suppression, and tumor metastasis; hence, TAMs have emerged as a hot topic of research in cancer therapy. This review focuses on three main aspects of TAMs. First, we summarize macrophage polarization along with the effects on the TME. Second, recent advances and challenges in cancer treatment and the role of M2-like TAMs in immune checkpoint blockade and CAR-T cell therapy are emphasized. Finally, factors, such as signaling pathways, associated with TAM polarization and potential strategies for targeting TAM repolarization to the M1 pro-inflammatory phenotype for cancer therapy are discussed. |
|---|---|
| AbstractList | Different stimuli can polarize macrophages into two basic types, M1 and M2. Tumor-associated macrophages (TAMs) in the tumor microenvironment (TME) are composed of heterogeneous subpopulations, which include the M1 anti-tumor and M2 pro-tumor phenotypes. TAMs predominantly play a M2-like tumor-promoting role in the TME and regulate various malignant effects, such as angiogenesis, immune suppression, and tumor metastasis; hence, TAMs have emerged as a hot topic of research in cancer therapy. This review focuses on three main aspects of TAMs. First, we summarize macrophage polarization along with the effects on the TME. Second, recent advances and challenges in cancer treatment and the role of M2-like TAMs in immune checkpoint blockade and CAR-T cell therapy are emphasized. Finally, factors, such as signaling pathways, associated with TAM polarization and potential strategies for targeting TAM repolarization to the M1 pro-inflammatory phenotype for cancer therapy are discussed. Different stimuli can polarize macrophages into two basic types, M1 and M2. Tumor-associated macrophages (TAMs) in the tumor microenvironment (TME) are composed of heterogeneous subpopulations, which include the M1 anti-tumor and M2 pro-tumor phenotypes. TAMs predominantly play a M2-like tumor-promoting role in the TME and regulate various malignant effects, such as angiogenesis, immune suppression, and tumor metastasis; hence, TAMs have emerged as a hot topic of research in cancer therapy. This review focuses on three main aspects of TAMs. First, we summarize macrophage polarization along with the effects on the TME. Second, recent advances and challenges in cancer treatment and the role of M2-like TAMs in immune checkpoint blockade and CAR-T cell therapy are emphasized. Finally, factors, such as signaling pathways, associated with TAM polarization and potential strategies for targeting TAM repolarization to the M1 pro-inflammatory phenotype for cancer therapy are discussed.Different stimuli can polarize macrophages into two basic types, M1 and M2. Tumor-associated macrophages (TAMs) in the tumor microenvironment (TME) are composed of heterogeneous subpopulations, which include the M1 anti-tumor and M2 pro-tumor phenotypes. TAMs predominantly play a M2-like tumor-promoting role in the TME and regulate various malignant effects, such as angiogenesis, immune suppression, and tumor metastasis; hence, TAMs have emerged as a hot topic of research in cancer therapy. This review focuses on three main aspects of TAMs. First, we summarize macrophage polarization along with the effects on the TME. Second, recent advances and challenges in cancer treatment and the role of M2-like TAMs in immune checkpoint blockade and CAR-T cell therapy are emphasized. Finally, factors, such as signaling pathways, associated with TAM polarization and potential strategies for targeting TAM repolarization to the M1 pro-inflammatory phenotype for cancer therapy are discussed. |
| Author | Liang, Yuanzheng Wang, Liang Gao, Jing |
| AuthorAffiliation | 1 Beijing Tongren Hospital, Capital Medical University , Beijing , China 2 Department of Hematology, Beijing Tongren Hospital, Capital Medical University , Beijing , China |
| AuthorAffiliation_xml | – name: 2 Department of Hematology, Beijing Tongren Hospital, Capital Medical University , Beijing , China – name: 1 Beijing Tongren Hospital, Capital Medical University , Beijing , China |
| Author_xml | – sequence: 1 givenname: Jing surname: Gao fullname: Gao, Jing – sequence: 2 givenname: Yuanzheng surname: Liang fullname: Liang, Yuanzheng – sequence: 3 givenname: Liang surname: Wang fullname: Wang, Liang |
| BookMark | eNp9kU1v3CAQhlGVqEnT_IDefOzFWwzYhkulaNWPlbZKpKZnNODxLpENLtiR0l9fshtVTQ7hMiNm3mcG3nfkxAePhHyo6IpzqT71bhyXFaOMraSUbcXfkPOqaUTJGRMn_-Vn5DKlO5qPUJzz-i0547UUoqH1Odn-3MPk_K64CQNE9wdmF3xx3Re3yxhieZVSsA5m7IofYGOY9rDDVGx8sQZvMRabvIQP8x4jTA_vyWkPQ8LLp3hBfn39crv-Xm6vv23WV9vS1lTOJaJSqNoOrBGmt1VTAxeMQycF9LbmtbHU0N42wFijgFpjsZVQGdP2XW-QX5DNkdsFuNNTdCPEBx3A6cNFiDsNcXZ2QI15DDaMKUWVyKlCIZmVEqSpK8VUZn0-sqbFjNhZ9HOE4Rn0ecW7vd6Fe62YpA1nGfDxCRDD7wXTrEeXLA4DeAxL0vkJlahVw9vcWh1b80-mFLH_N6ai-tFUfTBVP5qqj6ZmTftCY918cClv44ZXlH8BlyKrfQ |
| CitedBy_id | crossref_primary_10_1007_s00432_024_05777_4 crossref_primary_10_3390_cancers16030634 crossref_primary_10_1002_advs_202300953 crossref_primary_10_3389_froh_2025_1605978 crossref_primary_10_1186_s13048_025_01668_5 crossref_primary_10_1038_s41388_023_02924_y crossref_primary_10_34133_bmr_0086 crossref_primary_10_62347_MAXH5742 crossref_primary_10_3389_fcell_2025_1535339 crossref_primary_10_3389_fimmu_2023_1157291 crossref_primary_10_3389_fimmu_2025_1558091 crossref_primary_10_3390_cancers17091447 crossref_primary_10_1039_D5CS00088B crossref_primary_10_1007_s12672_025_02766_y crossref_primary_10_1177_15347354251349824 crossref_primary_10_1097_ot9_0000000000000063 crossref_primary_10_1007_s12094_024_03698_9 crossref_primary_10_1039_D4NR00284A crossref_primary_10_1007_s12032_025_02635_2 crossref_primary_10_1007_s00262_024_03915_y crossref_primary_10_1186_s12859_022_05091_1 crossref_primary_10_1007_s00432_024_06022_8 crossref_primary_10_3390_ijms26094097 crossref_primary_10_7759_cureus_92239 crossref_primary_10_3389_fimmu_2023_1264774 crossref_primary_10_1002_mc_23862 crossref_primary_10_3892_ijo_2024_5648 crossref_primary_10_1159_000540804 crossref_primary_10_4049_jimmunol_2400180 crossref_primary_10_3892_mmr_2025_13459 crossref_primary_10_3390_pharmaceutics15122695 crossref_primary_10_1002_ctm2_1036 crossref_primary_10_1186_s12964_023_01302_1 crossref_primary_10_3892_mmr_2025_13455 crossref_primary_10_1007_s00262_023_03596_z crossref_primary_10_3390_ijms24087116 crossref_primary_10_1002_hed_27734 crossref_primary_10_1007_s10067_025_07448_2 crossref_primary_10_3389_fonc_2025_1569651 crossref_primary_10_3389_fimmu_2024_1392940 crossref_primary_10_3389_fimmu_2025_1652166 crossref_primary_10_3389_fonc_2025_1582862 crossref_primary_10_3390_biom14020184 crossref_primary_10_3390_ijms25052830 crossref_primary_10_3390_cancers17081303 crossref_primary_10_1186_s12967_024_04856_x crossref_primary_10_1093_intimm_dxaf035 crossref_primary_10_3389_fmolb_2024_1522717 crossref_primary_10_3389_fimmu_2023_1130033 crossref_primary_10_1080_03639045_2025_2541789 crossref_primary_10_3389_fimmu_2024_1493978 crossref_primary_10_3389_fimmu_2025_1589153 crossref_primary_10_1007_s00262_024_03675_9 crossref_primary_10_2147_DDDT_S516001 crossref_primary_10_1007_s10565_025_10041_7 crossref_primary_10_1007_s00281_023_00988_2 crossref_primary_10_3390_cancers16162861 crossref_primary_10_3390_cancers17111858 crossref_primary_10_3389_fimmu_2024_1467016 crossref_primary_10_3389_fimmu_2024_1352946 crossref_primary_10_1002_iid3_70200 crossref_primary_10_3389_fimmu_2023_1212101 crossref_primary_10_1007_s13402_025_01056_7 crossref_primary_10_1038_s41417_025_00905_9 crossref_primary_10_1038_s41598_024_58208_2 crossref_primary_10_1002_smmd_70009 crossref_primary_10_1007_s10238_024_01530_w crossref_primary_10_1109_ACCESS_2023_3267738 crossref_primary_10_1186_s12943_025_02249_2 crossref_primary_10_1007_s13577_025_01246_3 crossref_primary_10_1186_s13045_025_01692_4 crossref_primary_10_3389_fonc_2023_1080720 crossref_primary_10_3390_ijms25137346 crossref_primary_10_3389_fimmu_2025_1521550 crossref_primary_10_3390_ijms252413722 crossref_primary_10_3389_fonc_2024_1450603 crossref_primary_10_3390_ijms252111340 crossref_primary_10_1002_VIW_20240103 crossref_primary_10_1002_cbdv_202402289 crossref_primary_10_1111_jcmm_70166 crossref_primary_10_3389_fimmu_2025_1573039 crossref_primary_10_3390_antiox12010116 crossref_primary_10_3390_ijms242115563 crossref_primary_10_2147_OTT_S483536 crossref_primary_10_3390_cancers15225313 crossref_primary_10_3390_biom15060761 crossref_primary_10_1038_s41416_023_02331_w crossref_primary_10_1002_ijc_35310 crossref_primary_10_1042_EBC20230002 crossref_primary_10_3390_cancers17010066 crossref_primary_10_3389_fcell_2024_1441081 crossref_primary_10_3389_fimmu_2025_1585139 crossref_primary_10_1159_000541881 crossref_primary_10_1039_D4BM01088D crossref_primary_10_1038_s41419_023_06211_2 crossref_primary_10_62347_BIQP4822 crossref_primary_10_1007_s00011_025_02077_6 crossref_primary_10_1038_s41598_025_02588_6 crossref_primary_10_1097_CM9_0000000000002426 crossref_primary_10_1002_cbdv_202402976 crossref_primary_10_3390_cancers17193099 crossref_primary_10_1038_s41467_024_48480_1 crossref_primary_10_3390_cancers17030342 crossref_primary_10_25259_Cytojournal_271_2024 crossref_primary_10_1007_s12015_024_10806_3 crossref_primary_10_3389_fonc_2023_1135456 crossref_primary_10_3389_fendo_2023_1187289 crossref_primary_10_3390_ijms26020811 crossref_primary_10_7717_peerj_18879 crossref_primary_10_3389_fimmu_2025_1639823 crossref_primary_10_3389_fimmu_2025_1526668 crossref_primary_10_1007_s12094_024_03598_y crossref_primary_10_1007_s10555_024_10174_x crossref_primary_10_3390_biomedicines13030539 crossref_primary_10_3390_cells14181481 crossref_primary_10_3390_ijms26115336 crossref_primary_10_3389_fphar_2024_1396616 crossref_primary_10_3389_fcell_2025_1520739 crossref_primary_10_1039_D5BM00202H crossref_primary_10_4081_ejh_2025_4178 crossref_primary_10_1002_ccs3_70034 crossref_primary_10_2174_0115672018299798240403062508 crossref_primary_10_1002_adbi_202400735 crossref_primary_10_3390_ijms26189070 crossref_primary_10_1002_advs_202502073 crossref_primary_10_1038_s41590_023_01675_y crossref_primary_10_1007_s11033_024_10058_x crossref_primary_10_3389_fimmu_2024_1382842 crossref_primary_10_3390_ijms26189199 crossref_primary_10_1038_s41698_024_00640_8 crossref_primary_10_3390_ijms25189779 crossref_primary_10_3389_fimmu_2025_1601756 crossref_primary_10_3389_fonc_2025_1570955 crossref_primary_10_3389_fimmu_2023_1295684 crossref_primary_10_1093_jnci_djaf065 crossref_primary_10_1007_s43032_023_01304_x crossref_primary_10_1021_acsptsci_5c00007 crossref_primary_10_3390_cells13221917 crossref_primary_10_3390_cancers17050723 crossref_primary_10_3389_fimmu_2025_1628571 crossref_primary_10_1039_D5TB00226E crossref_primary_10_1007_s11033_025_10738_2 crossref_primary_10_1007_s10238_025_01659_2 crossref_primary_10_1002_adhm_202301471 crossref_primary_10_3389_fimmu_2025_1558496 crossref_primary_10_1038_s41598_025_91979_w crossref_primary_10_1007_s12672_025_02396_4 crossref_primary_10_2147_IJN_S480553 crossref_primary_10_3390_ijms242417141 crossref_primary_10_3389_fimmu_2023_1136875 crossref_primary_10_1073_pnas_2409668121 crossref_primary_10_3389_fonc_2025_1643160 crossref_primary_10_3389_fonc_2025_1533990 crossref_primary_10_1007_s12672_025_03003_2 crossref_primary_10_3389_fimmu_2022_1012730 crossref_primary_10_3390_ijms25179737 crossref_primary_10_3389_fimmu_2025_1543096 crossref_primary_10_1007_s10142_024_01521_w crossref_primary_10_1097_CJI_0000000000000562 crossref_primary_10_1186_s12943_025_02375_x crossref_primary_10_1177_10732748251316604 crossref_primary_10_3389_fimmu_2025_1642091 crossref_primary_10_31083_j_fbl2909332 crossref_primary_10_1007_s40259_024_00657_2 crossref_primary_10_1097_CAD_0000000000001573 crossref_primary_10_3389_fimmu_2025_1648987 crossref_primary_10_1186_s12967_025_06235_6 crossref_primary_10_3389_fimmu_2025_1589329 crossref_primary_10_3390_cells13171428 crossref_primary_10_1038_s41698_025_01092_4 crossref_primary_10_1007_s00262_025_04118_9 crossref_primary_10_3390_biomedicines12010191 crossref_primary_10_3389_fimmu_2024_1485174 crossref_primary_10_17816_MAJ639999 crossref_primary_10_3390_ijms25095007 crossref_primary_10_55475_jcgtm_vol3_iss6_2024_474 crossref_primary_10_1007_s11538_025_01466_6 crossref_primary_10_1007_s00210_024_03313_2 crossref_primary_10_1038_s41598_025_16785_w crossref_primary_10_1002_tox_23675 crossref_primary_10_3389_fphar_2025_1540027 crossref_primary_10_1007_s13402_025_01051_y crossref_primary_10_3390_cancers16061202 crossref_primary_10_1186_s12951_024_02612_3 crossref_primary_10_1097_MD_0000000000038991 crossref_primary_10_3390_pharmaceutics15082166 crossref_primary_10_3389_fimmu_2025_1649147 crossref_primary_10_1007_s11010_025_05222_1 crossref_primary_10_1007_s11864_024_01260_x crossref_primary_10_3389_fonc_2023_1125868 crossref_primary_10_2147_JIR_S493656 crossref_primary_10_1038_s41388_025_03497_8 crossref_primary_10_1080_19768354_2024_2336249 crossref_primary_10_1172_jci_insight_181903 crossref_primary_10_3892_ijo_2024_5705 crossref_primary_10_1038_s41419_024_06758_8 crossref_primary_10_1371_journal_ppat_1012689 crossref_primary_10_1002_cbin_12226 crossref_primary_10_3389_fphar_2025_1642957 crossref_primary_10_1007_s12672_025_03258_9 crossref_primary_10_3748_wjg_v30_i30_3626 crossref_primary_10_3748_wjg_v30_i30_3625 crossref_primary_10_3389_fphar_2024_1289957 crossref_primary_10_1021_acs_est_4c08009 crossref_primary_10_3748_wjg_v30_i41_4490 crossref_primary_10_3390_life15081170 crossref_primary_10_1007_s00262_024_03912_1 crossref_primary_10_1038_s41420_025_02484_y crossref_primary_10_3390_ijms26104511 crossref_primary_10_3390_cells14151209 crossref_primary_10_1038_s41698_025_00967_w crossref_primary_10_1007_s00210_024_03601_x crossref_primary_10_3389_fonc_2022_1096717 crossref_primary_10_1007_s12094_024_03802_z crossref_primary_10_1038_s41419_024_06976_0 crossref_primary_10_1007_s12026_024_09479_4 crossref_primary_10_1007_s12282_023_01491_0 crossref_primary_10_3389_fonc_2024_1449696 crossref_primary_10_3389_fimmu_2025_1542526 crossref_primary_10_3748_wjg_v31_i3_99983 crossref_primary_10_2147_IJN_S479533 crossref_primary_10_1002_ijc_35035 crossref_primary_10_1002_mco2_658 crossref_primary_10_3892_ijo_2024_5684 crossref_primary_10_2147_ITT_S485672 crossref_primary_10_1186_s12951_023_02122_8 crossref_primary_10_1038_s41388_025_03452_7 crossref_primary_10_31083_j_fbl2809207 crossref_primary_10_3389_fimmu_2025_1556209 crossref_primary_10_3390_biomedicines13040844 crossref_primary_10_3390_biom15071010 crossref_primary_10_3389_fimmu_2025_1626243 crossref_primary_10_3390_cancers16071280 crossref_primary_10_2147_IJN_S507038 crossref_primary_10_1002_cnr2_2146 crossref_primary_10_1002_ctm2_70054 crossref_primary_10_3389_fimmu_2023_1165602 crossref_primary_10_4251_wjgo_v16_i10_4064 crossref_primary_10_1007_s00262_024_03666_w crossref_primary_10_1007_s12672_025_03509_9 crossref_primary_10_3389_fimmu_2022_1059376 crossref_primary_10_3390_ijms25116141 crossref_primary_10_1007_s12032_025_02969_x crossref_primary_10_3390_cells14070530 crossref_primary_10_3389_fimmu_2025_1610466 crossref_primary_10_1155_jimr_4109934 crossref_primary_10_3390_cells14110828 crossref_primary_10_1186_s12967_023_04716_0 crossref_primary_10_1007_s11010_025_05281_4 crossref_primary_10_1007_s00262_025_04116_x crossref_primary_10_4251_wjgo_v17_i9_108649 crossref_primary_10_1186_s12951_025_03663_w crossref_primary_10_1111_cns_14239 crossref_primary_10_3892_ijmm_2023_5327 crossref_primary_10_3389_fimmu_2025_1563303 crossref_primary_10_1007_s11033_024_09266_2 crossref_primary_10_1007_s12672_025_01897_6 crossref_primary_10_3390_biom13040661 crossref_primary_10_3389_fimmu_2022_1057746 |
| Cites_doi | 10.1158/2326-6066.CIR-13-0150 10.1016/j.bbcan.2021.188547 10.1186/s12967-020-02618-z 10.1021/acs.nanolett.1c00209 10.1136/jitc-2019-000489 10.1016/j.it.2017.03.001 10.1093/neuonc/noy032 10.4161/onci.28926 10.2147/IJN.S281890 10.1002/cam4.2332 10.1038/s41419-021-03450-z 10.1186/s12943-020-01165-x 10.1021/acs.nanolett.1c01401 10.1016/j.ymthe.2020.06.003 10.1111/jcmm.15751 10.3389/fimmu.2021.676301 10.1186/s13045-020-00887-1 10.1126/science.aay9189 10.1182/blood-2008-12-172825 10.1186/s13046-018-0815-2 10.3109/08820139.2012.695417 10.7150/thno.45261 10.1038/nri2448 10.1038/s41467-021-22923-5 10.4049/jimmunol.181.6.3733 10.1186/s13059-020-02140-x 10.1016/j.jconrel.2020.02.011 10.1111/vco.12206 10.1371/journal.pone.0153550 10.1038/s41590-018-0226-8 10.7717/peerj.8721 10.1007/s10549-014-3164-7 10.1136/jitc-2019-000308 10.3389/fimmu.2020.01947 10.1186/s13046-020-01637-4 10.1016/j.abb.2014.09.005 10.1146/annurev-pathol-042020-042741 10.1002/jcp.26429 10.1016/j.cell.2021.09.020 10.1186/s13046-020-01676-x 10.1016/j.it.2004.09.015 10.1093/annonc/mdf078 10.1016/j.neo.2020.08.006 10.3390/ijms19082208 10.1111/imr.12218 10.1016/j.canlet.2016.01.043 10.1172/JCI23298 10.1038/s41467-021-20893-2 10.1016/j.canlet.2013.11.013 10.1016/j.cellimm.2020.104119 10.1016/j.ccell.2019.11.004 10.1002/JLB.3A0318-108R 10.1002/cam4.1670 10.1038/s41568-020-00323-z 10.1084/jem.20160392 10.1182/bloodadvances.2020003871 10.1016/j.jep.2018.12.003 10.1016/j.bbcan.2020.188434 10.7150/thno.53749 10.1016/bs.acr.2019.03.002 10.1126/science.1251456 10.1002/smll.202003543 10.1016/j.tips.2020.08.003 10.1038/ni.3691 10.7150/thno.51864 10.1038/s41467-019-12384-2 10.1038/s41577-019-0259-8 10.1038/s41587-020-0462-y 10.2147/CMAR.S203010 10.1186/s13046-018-0792-5 10.1158/0008-5472.CAN-20-2990 10.1111/cas.14616 10.1021/acs.nanolett.9b02916 10.1002/adma.201902007 10.1186/s13046-020-01786-6 10.1158/0008-5472.CAN-20-1885 |
| ContentType | Journal Article |
| Copyright | Copyright © 2022 Gao, Liang and Wang. Copyright © 2022 Gao, Liang and Wang 2022 Gao, Liang and Wang |
| Copyright_xml | – notice: Copyright © 2022 Gao, Liang and Wang. – notice: Copyright © 2022 Gao, Liang and Wang 2022 Gao, Liang and Wang |
| DBID | AAYXX CITATION 7X8 5PM DOA |
| DOI | 10.3389/fimmu.2022.888713 |
| DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1664-3224 |
| ExternalDocumentID | oai_doaj_org_article_e7dae62299094dae9e482c88a8b51929 PMC9280632 10_3389_fimmu_2022_888713 |
| GrantInformation_xml | – fundername: ; grantid: 82178101, 81873450 |
| GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EBS EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RNS RPM 7X8 5PM |
| ID | FETCH-LOGICAL-c508t-ee99e97dacb4bfc165a3423ad84afc535bc0b0fc6a2269a0cbce78a1bb7fdfbe3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 399 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000841686300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1664-3224 |
| IngestDate | Fri Oct 03 12:52:22 EDT 2025 Thu Aug 21 18:27:21 EDT 2025 Thu Sep 04 16:05:33 EDT 2025 Sat Nov 29 05:52:28 EST 2025 Tue Nov 18 22:13:09 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c508t-ee99e97dacb4bfc165a3423ad84afc535bc0b0fc6a2269a0cbce78a1bb7fdfbe3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Edited by: Sukh Mahendra Singh, Banaras Hindu University, India Reviewed by: Naveen Kumar Vishvakarma, Guru Ghasidas Vishwavidyalaya, India; Santosh Kumar, National Institute of Technology Rourkela, India This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology |
| OpenAccessLink | https://doaj.org/article/e7dae62299094dae9e482c88a8b51929 |
| PMID | 35844605 |
| PQID | 2691459637 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_e7dae62299094dae9e482c88a8b51929 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9280632 proquest_miscellaneous_2691459637 crossref_primary_10_3389_fimmu_2022_888713 crossref_citationtrail_10_3389_fimmu_2022_888713 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-06-30 |
| PublicationDateYYYYMMDD | 2022-06-30 |
| PublicationDate_xml | – month: 06 year: 2022 text: 2022-06-30 day: 30 |
| PublicationDecade | 2020 |
| PublicationTitle | Frontiers in immunology |
| PublicationYear | 2022 |
| Publisher | Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Media S.A |
| References | Wei (B71) 2021; 21 Yang (B72) 2020; 41 Wu (B17) 2020; 8 Chen (B63) 2019; 232 Klichinsky (B76) 2020; 38 Wu (B8) 2017; 387 McAllister (B68) 2019; 36 Sylvestre (B7) 2020; 32 Bagchi (B27) 2021; 16 Zhang (B30) 2020; 8 Fang (B32) 2021; 40 Xiao (B10) 2018; 37 Larson (B26) 2021; 21 Colin (B2) 2014; 262 Yu (B28) 2021; 12 Koh (B60) 2018; 19 Zhu (B43) 2019; 11 Zhang (B47) 2016; 11 Liu (B59) 2020; 16 Weichand (B24) 2017; 214 Liu (B14) 2020; 11 Rodriguez-Garcia (B34) 2021; 12 Luo (B33) 2020; 111 Lu (B44) 2020; 13 Yu (B39) 2019; 10 Bohn (B56) 2018; 19 Santoni (B75) 2021; 1876 Obermajer (B22) 2012; 41 Nejman (B67) 2020; 368 Yang (B51) 2019; 8 Jia (B62) 2014; 148 Gu (B74) 2021; 21 Sa (B41) 2020; 21 Lizotte (B70) 2014; 3 Kim (B20) 2020; 22 Ivashkiv (B52) 2020; 20 Guo (B64) 2020; 28 Osipov (B6) 2019; 143 Shapouri-Moghaddam (B4) 2018; 233 Di Martile (B46) 2020; 8 Zhang (B54) 2021; 11 Shao (B66) 2020; 15 Mantovani (B5) 2004; 25 Arnold (B19) 2014; 2 Tao (B38) 2020; 39 Wang (B40) 2020; 10 Zhou (B57) 2018; 7 Bagley (B29) 2018; 20 Nakao (B12) 2005; 115 Xun (B65) 2021; 11 Mosser (B1) 2008; 8 Shu (B9) 2020; 1874 La Fleur (B23) 2021; 81 Mukherjee (B61) 2018; 37 Morad (B25) 2021; 184 Huffaker (B35) 2021; 12 Van den Bossche (B53) 2017; 38 Le (B36) 2021; 5 Benoit (B69) 2008; 181 Yang (B31) 2020; 19 Hagemann (B50) 2009; 113 Fu (B15) 2020; 353 Carvalho (B21) 2017; 15 Wang (B49) 2014; 344 Li (B42) 2020; 321 Pang (B73) 2020; 20 Naito (B18) 2014; 564 Zhong (B37) 2020; 39 Xu (B55) 2021; 12 Anderson (B3) 2021; 81 Handa (B58) 2019; 105 Villarino (B48) 2017; 18 Hwang (B16) 2020; 18 Wang (B45) 2020; 24 Wang (B11) 2014; 345 Fujimoto (B13) 2002; 13 |
| References_xml | – volume: 2 year: 2014 ident: B19 article-title: Tumoral Immune Suppression by Macrophages Expressing Fibroblast Activation Protein-α and Heme Oxygenase-1 publication-title: Cancer Immunol Res doi: 10.1158/2326-6066.CIR-13-0150 – volume: 1876 start-page: 188547 year: 2021 ident: B75 article-title: Manipulating Macrophage Polarization in Cancer Patients: From Nanoparticles to Human Chimeric Antigen Receptor Macrophages publication-title: Biochim Biophys Acta Rev Cancer doi: 10.1016/j.bbcan.2021.188547 – volume: 18 start-page: 443 year: 2020 ident: B16 article-title: Tumor-Associated Macrophage, Angiogenesis and Lymphangiogenesis Markers Predict Prognosis of non-Small Cell Lung Cancer Patients publication-title: J Transl Med doi: 10.1186/s12967-020-02618-z – volume: 21 year: 2021 ident: B71 article-title: Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded Escherichia Coli Combined With Immunogenic Cell Death for Cancer Immunotherapy publication-title: Nano Lett doi: 10.1021/acs.nanolett.1c00209 – volume: 8 year: 2020 ident: B46 article-title: Melanoma-Specific Bcl-2 Promotes a Protumoral M2-Like Phenotype by Tumor-Associated Macrophages publication-title: J Immunother Cancer doi: 10.1136/jitc-2019-000489 – volume: 38 start-page: 395 year: 2017 ident: B53 article-title: Macrophage Immunometabolism: Where Are We (Going) publication-title: Trends Immunol doi: 10.1016/j.it.2017.03.001 – volume: 20 year: 2018 ident: B29 article-title: CAR T-Cell Therapy for Glioblastoma: Recent Clinical Advances and Future Challenges publication-title: Neuro Oncol doi: 10.1093/neuonc/noy032 – volume: 3 year: 2014 ident: B70 article-title: Attenuated Listeria Monocytogenes Reprograms M2-Polarized Tumor-Associated Macrophages in Ovarian Cancer Leading to iNOS-Mediated Tumor Cell Lysis publication-title: Oncoimmunology doi: 10.4161/onci.28926 – volume: 15 year: 2020 ident: B66 article-title: Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate publication-title: Int J Nanomed doi: 10.2147/IJN.S281890 – volume: 8 year: 2019 ident: B51 article-title: Engineering Macrophages to Phagocytose Cancer Cells by Blocking the CD47/SIRPα Axis publication-title: Cancer Med doi: 10.1002/cam4.2332 – volume: 12 start-page: 162 year: 2021 ident: B55 article-title: ECT2 Overexpression Promotes the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma via the ECT2/PLK1/PTEN Pathway publication-title: Cell Death Dis doi: 10.1038/s41419-021-03450-z – volume: 19 start-page: 41 year: 2020 ident: B31 article-title: CCL2-CCR2 Axis Recruits Tumor Associated Macrophages to Induce Immune Evasion Through PD-1 Signaling in Esophageal Carcinogenesis publication-title: Mol Cancer doi: 10.1186/s12943-020-01165-x – volume: 21 year: 2021 ident: B74 article-title: Ferroptosis-Strengthened Metabolic and Inflammatory Regulation of Tumor-Associated Macrophages Provokes Potent Tumoricidal Activities publication-title: Nano Lett doi: 10.1021/acs.nanolett.1c01401 – volume: 28 year: 2020 ident: B64 article-title: Exosomes: A Potential Therapeutic Tool Targeting Communications Between Tumor Cells and Macrophages publication-title: Mol Ther doi: 10.1016/j.ymthe.2020.06.003 – volume: 24 year: 2020 ident: B45 article-title: CtBP1 Promotes Tumour-Associated Macrophage Infiltration and Progression in non-Small-Cell Lung Cancer publication-title: J Cell Mol Med doi: 10.1111/jcmm.15751 – volume: 12 year: 2021 ident: B28 article-title: Immunotherapy for Glioblastoma: Current Progress and Challenges publication-title: Front Immunol doi: 10.3389/fimmu.2021.676301 – volume: 13 start-page: 62 year: 2020 ident: B44 article-title: Oct4 Promotes M2 Macrophage Polarization Through Upregulation of Macrophage Colony-Stimulating Factor in Lung Cancer publication-title: J Hematol Oncol doi: 10.1186/s13045-020-00887-1 – volume: 368 year: 2020 ident: B67 article-title: The Human Tumor Microbiome is Composed of Tumor Type-Specific Intracellular Bacteria publication-title: Science doi: 10.1126/science.aay9189 – volume: 113 year: 2009 ident: B50 article-title: Regulation of Macrophage Function in Tumors: The Multifaceted Role of NF-Kappab publication-title: Blood doi: 10.1182/blood-2008-12-172825 – volume: 37 start-page: 143 year: 2018 ident: B10 article-title: M1-Like Tumor-Associated Macrophages Activated by Exosome-Transferred THBS1 Promote Malignant Migration in Oral Squamous Cell Carcinoma publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-018-0815-2 – volume: 41 year: 2012 ident: B22 article-title: PGE(2)-Driven Induction and Maintenance of Cancer-Associated Myeloid-Derived Suppressor Cells publication-title: Immunol Invest doi: 10.3109/08820139.2012.695417 – volume: 10 year: 2020 ident: B40 article-title: FOXO1 Promotes Tumor Progression by Increased M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma publication-title: Theranostics doi: 10.7150/thno.45261 – volume: 8 year: 2008 ident: B1 article-title: Exploring the Full Spectrum of Macrophage Activation publication-title: Nat Rev Immunol doi: 10.1038/nri2448 – volume: 12 start-page: 2620 year: 2021 ident: B35 article-title: A Stat1 Bound Enhancer Promotes Nampt Expression and Function Within Tumor Associated Macrophages publication-title: Nat Commun doi: 10.1038/s41467-021-22923-5 – volume: 181 year: 2008 ident: B69 article-title: Macrophage Polarization in Bacterial Infections publication-title: J Immunol doi: 10.4049/jimmunol.181.6.3733 – volume: 21 start-page: 216 year: 2020 ident: B41 article-title: Transcriptional Regulatory Networks of Tumor-Associated Macrophages That Drive Malignancy in Mesenchymal Glioblastoma publication-title: Genome Biol doi: 10.1186/s13059-020-02140-x – volume: 321 start-page: 23 year: 2020 ident: B42 article-title: Remodeling Tumor Immune Microenvironment via Targeted Blockade of PI3K-γ and CSF-1/CSF-1R Pathways in Tumor Associated Macrophages for Pancreatic Cancer Therapy publication-title: J Control Release doi: 10.1016/j.jconrel.2020.02.011 – volume: 15 year: 2017 ident: B21 article-title: High COX-2 Expression Is Associated With Increased Angiogenesis, Proliferation and Tumoural Inflammatory Infiltrate in Canine Malignant Mammary Tumours: A Multivariate Survival Study publication-title: Vet Comp Oncol doi: 10.1111/vco.12206 – volume: 11 year: 2016 ident: B47 article-title: Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo publication-title: PloS One doi: 10.1371/journal.pone.0153550 – volume: 19 year: 2018 ident: B56 article-title: Tumor Immunoevasion via Acidosis-Dependent Induction of Regulatory Tumor-Associated Macrophages publication-title: Nat Immunol doi: 10.1038/s41590-018-0226-8 – volume: 8 year: 2020 ident: B17 article-title: Tumour-Associated Macrophages Mediate the Invasion and Metastasis of Bladder Cancer Cells Through CXCL8 publication-title: PeerJ doi: 10.7717/peerj.8721 – volume: 148 start-page: 291 year: 2014 ident: B62 article-title: Emodin Suppresses Pulmonary Metastasis of Breast Cancer Accompanied With Decreased Macrophage Recruitment and M2 Polarization in the Lungs publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-014-3164-7 – volume: 8 year: 2020 ident: B30 article-title: Interferon Gamma Inhibits CXCL8-CXCR2 Axis Mediated Tumor-Associated Macrophages Tumor Trafficking and Enhances Anti-PD1 Efficacy in Pancreatic Cancer publication-title: J Immunother Cancer doi: 10.1136/jitc-2019-000308 – volume: 11 year: 2020 ident: B14 article-title: “Re-Educating”Tumor Associated Macrophages as a Novel Immunotherapy Strategy for Neuroblastoma publication-title: Front Immunol doi: 10.3389/fimmu.2020.01947 – volume: 39 start-page: 132 year: 2020 ident: B37 article-title: CPEB3 Inhibits Epithelial-Mesenchymal Transition by Disrupting the Crosstalk Between Colorectal Cancer Cells and Tumor-Associated Macrophages via IL-6r/STAT3 Signaling publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-020-01637-4 – volume: 564 year: 2014 ident: B18 article-title: Heme Oxygenase-1 and Anti-Inflammatory M2 Macrophages publication-title: Arch Biochem Biophys doi: 10.1016/j.abb.2014.09.005 – volume: 16 year: 2021 ident: B27 article-title: Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance publication-title: Annu Rev Pathol doi: 10.1146/annurev-pathol-042020-042741 – volume: 233 year: 2018 ident: B4 article-title: Macrophage Plasticity, Polarization, and Function in Health and Disease publication-title: J Cell Physiol doi: 10.1002/jcp.26429 – volume: 184 year: 2021 ident: B25 article-title: Hallmarks of Response, Resistance, and Toxicity to Immune Checkpoint Blockade publication-title: Cell doi: 10.1016/j.cell.2021.09.020 – volume: 39 start-page: 191 year: 2020 ident: B38 article-title: Linc00514 Promotes Breast Cancer Metastasis and M2 Polarization of Tumor-Associated Macrophages via Jagged1-Mediated Notch Signaling Pathway publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-020-01676-x – volume: 25 year: 2004 ident: B5 article-title: The Chemokine System in Diverse Forms of Macrophage Activation and Polarization publication-title: Trends Immunol doi: 10.1016/j.it.2004.09.015 – volume: 13 year: 2002 ident: B13 article-title: Clinical Implications of Expression of Interleukin-8 Related to Myometrial Invasion With Angiogenesis in Uterine Endometrial Cancers publication-title: Ann Oncol doi: 10.1093/annonc/mdf078 – volume: 22 year: 2020 ident: B20 article-title: Breast Cancer Cell Debris Diminishes Therapeutic Efficacy Through Heme Oxygenase-1-Mediated Inactivation of M1-Like Tumor-Associated Macrophages publication-title: Neoplasia doi: 10.1016/j.neo.2020.08.006 – volume: 19 start-page: 2208 year: 2018 ident: B60 article-title: Chemopreventive Effects of Phytochemicals and Medicines on M1/M2 Polarized Macrophage Role in Inflammation-Related Diseases publication-title: Int J Mol Sci doi: 10.3390/ijms19082208 – volume: 262 year: 2014 ident: B2 article-title: Macrophage Phenotypes in Atherosclerosis publication-title: Immunol Rev doi: 10.1111/imr.12218 – volume: 387 year: 2017 ident: B8 article-title: Tumor Microenvironment and Therapeutic Response publication-title: Cancer Lett doi: 10.1016/j.canlet.2016.01.043 – volume: 115 year: 2005 ident: B12 article-title: Infiltration of COX-2-Expressing Macrophages Is a Prerequisite for IL-1 Beta-Induced Neovascularization and Tumor Growth publication-title: J Clin Invest doi: 10.1172/JCI23298 – volume: 12 start-page: 877 year: 2021 ident: B34 article-title: CAR-T Cell-Mediated Depletion of Immunosuppressive Tumor-Associated Macrophages Promotes Endogenous Antitumor Immunity and Augments Adoptive Immunotherapy publication-title: Nat Commun doi: 10.1038/s41467-021-20893-2 – volume: 345 year: 2014 ident: B11 article-title: CD68(+)HLA-DR(+) M1-Like Macrophages Promote Motility of HCC Cells via NF-κb/FAK Pathway publication-title: Cancer Lett doi: 10.1016/j.canlet.2013.11.013 – volume: 353 start-page: 104119 year: 2020 ident: B15 article-title: The Roles of Tumor-Associated Macrophages in Tumor Angiogenesis and Metastasis publication-title: Cell Immunol doi: 10.1016/j.cellimm.2020.104119 – volume: 36 year: 2019 ident: B68 article-title: The Tumor Microbiome in Pancreatic Cancer: Bacteria and Beyond publication-title: Cancer Cell doi: 10.1016/j.ccell.2019.11.004 – volume: 105 year: 2019 ident: B58 article-title: Iron Alters Macrophage Polarization Status and Leads to Steatohepatitis and Fibrogenesis publication-title: J Leukoc Biol doi: 10.1002/JLB.3A0318-108R – volume: 7 year: 2018 ident: B57 article-title: Iron Overloaded Polarizes Macrophage to Proinflammation Phenotype Through ROS/acetyl-P53 Pathway publication-title: Cancer Med doi: 10.1002/cam4.1670 – volume: 21 year: 2021 ident: B26 article-title: Recent Advances and Discoveries in the Mechanisms and Functions of CAR T Cells publication-title: Nat Rev Cancer doi: 10.1038/s41568-020-00323-z – volume: 214 year: 2017 ident: B24 article-title: S1PR1 on Tumor-Associated Macrophages Promotes Lymphangiogenesis and Metastasis via NLRP3/IL-1β publication-title: J Exp Med doi: 10.1084/jem.20160392 – volume: 5 year: 2021 ident: B36 article-title: Mantle Cell Lymphoma Polarizes Tumor-Associated Macrophages Into M2-Like Macrophages, Which in Turn Promote Tumorigenesis publication-title: Blood Adv doi: 10.1182/bloodadvances.2020003871 – volume: 232 start-page: 11 year: 2019 ident: B63 article-title: Water Extract of Ginseng and Astragalus Regulates Macrophage Polarization and Synergistically Enhances DDP's Anticancer Effect publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2018.12.003 – volume: 1874 start-page: 188434 year: 2020 ident: B9 article-title: Targeting Tumor-Associated Macrophages for Cancer Immunotherapy publication-title: Biochim Biophys Acta Rev Cancer doi: 10.1016/j.bbcan.2020.188434 – volume: 11 year: 2021 ident: B54 article-title: Lactate-Induced M2 Polarization of Tumor-Associated Macrophages Promotes the Invasion of Pituitary Adenoma by Secreting CCL17 publication-title: Theranostics doi: 10.7150/thno.53749 – volume: 143 start-page: 63 year: 2019 ident: B6 article-title: From Immune Checkpoints to Vaccines: The Past, Present and Future of Cancer Immunotherapy publication-title: Adv Cancer Res doi: 10.1016/bs.acr.2019.03.002 – volume: 344 year: 2014 ident: B49 article-title: The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation publication-title: Science doi: 10.1126/science.1251456 – volume: 16 year: 2020 ident: B59 article-title: A Biomimetic Polymer Magnetic Nanocarrier Polarizing Tumor-Associated Macrophages for Potentiating Immunotherapy publication-title: Small doi: 10.1002/smll.202003543 – volume: 41 year: 2020 ident: B72 article-title: Tackling TAMs for Cancer Immunotherapy: It's Nano Time publication-title: Trends Pharmacol Sci doi: 10.1016/j.tips.2020.08.003 – volume: 18 year: 2017 ident: B48 article-title: Mechanisms and Consequences of Jak-STAT Signaling in the Immune System publication-title: Nat Immunol doi: 10.1038/ni.3691 – volume: 11 year: 2021 ident: B65 article-title: Cancer-Derived Exosomal miR-138-5p Modulates Polarization of Tumor-Associated Macrophages Through Inhibition of KDM6B publication-title: Theranostics doi: 10.7150/thno.51864 – volume: 10 start-page: 4353 year: 2019 ident: B39 article-title: Modulation of M2 Macrophage Polarization by the Crosstalk Between Stat6 and Trim24 publication-title: Nat Commun doi: 10.1038/s41467-019-12384-2 – volume: 20 year: 2020 ident: B52 article-title: The Hypoxia-Lactate Axis Tempers Inflammation publication-title: Nat Rev Immunol doi: 10.1038/s41577-019-0259-8 – volume: 38 year: 2020 ident: B76 article-title: Human Chimeric Antigen Receptor Macrophages for Cancer Immunotherapy publication-title: Nat Biotechnol doi: 10.1038/s41587-020-0462-y – volume: 11 year: 2019 ident: B43 article-title: NSE From Diffuse Large B-Cell Lymphoma Cells Regulates Macrophage Polarization publication-title: Cancer Manag Res doi: 10.2147/CMAR.S203010 – volume: 37 start-page: 168 year: 2018 ident: B61 article-title: Phytosomal Curcumin Causes Natural Killer Cell-Dependent Repolarization of Glioblastoma (GBM) Tumor-Associated Microglia/Macrophages and Elimination of GBM and GBM Stem Cells publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-018-0792-5 – volume: 81 year: 2021 ident: B3 article-title: Macrophage-Based Approaches for Cancer Immunotherapy publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-20-2990 – volume: 111 year: 2020 ident: B33 article-title: Lipid Accumulation in Macrophages Confers Protumorigenic Polarization and Immunity in Gastric Cancer publication-title: Cancer Sci doi: 10.1111/cas.14616 – volume: 20 year: 2020 ident: B73 article-title: Metal-Organic Framework Nanoparticles for Ameliorating Breast Cancer-Associated Osteolysis publication-title: Nano Lett doi: 10.1021/acs.nanolett.9b02916 – volume: 32 year: 2020 ident: B7 article-title: Progress on Modulating Tumor-Associated Macrophages With Biomaterials publication-title: Adv Mater doi: 10.1002/adma.201902007 – volume: 40 start-page: 4 year: 2021 ident: B32 article-title: Progranulin Induces Immune Escape in Breast Cancer via Up-Regulating PD-L1 Expression on Tumor-Associated Macrophages (TAMs) and Promoting CD8+ T Cell Exclusion publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-020-01786-6 – volume: 81 year: 2021 ident: B23 article-title: Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-20-1885 |
| SSID | ssj0000493335 |
| Score | 2.6967573 |
| SecondaryResourceType | review_article |
| Snippet | Different stimuli can polarize macrophages into two basic types, M1 and M2. Tumor-associated macrophages (TAMs) in the tumor microenvironment (TME) are... |
| SourceID | doaj pubmedcentral proquest crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
| StartPage | 888713 |
| SubjectTerms | cancer therapy Immunology polarization signaling pathways tumor microenvironment tumor-associated macrophages |
| Title | Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy |
| URI | https://www.proquest.com/docview/2691459637 https://pubmed.ncbi.nlm.nih.gov/PMC9280632 https://doaj.org/article/e7dae62299094dae9e482c88a8b51929 |
| Volume | 13 |
| WOSCitedRecordID | wos000841686300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1664-3224 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000493335 issn: 1664-3224 databaseCode: DOA dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1664-3224 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000493335 issn: 1664-3224 databaseCode: M~E dateStart: 20100101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEB7a0EIvpU-6fQQVeiqY2JZtScc2JDSQpIGmZW9iJEvslq637KOQS397ZyxvWF_aSy_C2DKWPo2lGaTvG4B3Dn3jfOkynxcxq1DFTMvWUYEyYhm961mu387V5aWeTs3VXqovPhOW5IETcEdBtRiakmdNU9GlCZUuvdaoHTkfZU_dI69nL5j6nvxeKWWdtjEpCjNHcb5YbCkeLEuyDYoS5Ggh6vX6R07m-Ijk3ppz-ggeDs6i-JAa-RjuhO4J3E_pI2-ewvmXGTLdSVxxfDoQKsXnKK63i-Uq2yEfWnGBnKlrRnPHWpx14piHeiXOmBsyMLBunsHX05Pr40_ZkB0h8-RUbbIQjAmG0PGuctEXTY2s5oetrjD6WtbO5y6PvkHysAzm3vmgNBbOqdhGF-RzOOiWXXgBQnqFpnaFaXNZ1QEN02sbj8jhELb5BPIdVNYP0uGcweKHpRCC0bU9upbRtQndCby_feVn0s34W-WPjP9tRZa87m-QIdjBEOy_DGECb3ejZ-kX4X0P7MJyu7bU_aKqaaZRE1CjYR19cfykm896sW3DW8-yfPk_mvgKHnCv03HD13CwWW3DG7jnf23m69Uh3FVTfdjbMZUXv0_-ADxu_Lw |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Shaping+Polarization+Of+Tumor-Associated+Macrophages+In+Cancer+Immunotherapy&rft.jtitle=Frontiers+in+immunology&rft.au=Gao%2C+Jing&rft.au=Liang%2C+Yuanzheng&rft.au=Wang%2C+Liang&rft.date=2022-06-30&rft.issn=1664-3224&rft.eissn=1664-3224&rft.volume=13&rft.spage=888713&rft_id=info:doi/10.3389%2Ffimmu.2022.888713&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon |